Expression of the p56lck Y505F Mutation in CD45-Deficient Mice Rescues Thymocyte Development
AUTOR(ES)
Seavitt, John R.
FONTE
American Society for Microbiology
RESUMO
Mice deficient in the transmembrane protein tyrosine phosphatase CD45 exhibit a block in thymocyte development. To determine whether the block in thymocyte development was due to the inability to dephosphorylate the inhibitory phosphorylation site (Y505) in p56lck (Lck), we generated CD45-deficient mice that express transgenes for the Lck Y505F mutation and the DO11.10 T-cell antigen receptor (TCR). CD4 single-positive T cells developed and accumulated in the periphery. Treatment with antigen resulted in thymocyte apoptosis and the loss of transgenic-TCR-bearing cells. Peripheral CD45-deficient T cells from the mice expressing both transgenes responded to antigen by increasing CD69 expression, interleukin-2 production, and proliferation. These results indicate that thymocyte development requires the dephosphorylation of the inhibitory site in Lck by CD45.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=104379Documentos Relacionados
- Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression.
- Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice
- p56Lck anchors CD4 to distinct microdomains on microvilli
- The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity.
- The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site.
